Position history for Boston Trust Walden Corp's holdings in JAZZ PHARMACEUTICALS PLC
Boston Trust Walden Corp holds 488,661 shares of JAZZ (JAZZ PHARMACEUTICALS PLC), worth $92.4M as of 2026-Q1. The position was increased (+24.1% shares). JAZZ represents 0.8% of Boston Trust Walden Corp's portfolio.
Current Value
$92.4M
Current Shares
488,661
Total Value Change
+$70.3M
Total Shares Change
+310,649
Other major holders of JAZZ: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 488,661 |
+24.1% |
| $92.4M |
| 0.8% |
| $186.67 |
51 |
| 2025-Q4 | Decreased | 393,911 | -3.6% | $67M | 0.5% | $170.82 | 0 |
| 2025-Q3 | Increased | 408,827 | +0.2% | $53.9M | 0.4% | $129.02 | 35 |
| 2025-Q2 | Increased | 407,897 | +129.1% | $43.3M | 0.3% | $106.90 | 56 |
| 2025-Q1 | New | 178,012 | - | $22.1M | 0.2% | $122.92 | 47 |